Jackson Andrew C. 4
4 · Brooklyn ImmunoTherapeutics, Inc. · Filed Jun 6, 2022
Insider Transaction Report
Form 4
Jackson Andrew C.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-06-03+664,800→ 664,800 totalExercise: $0.61Exp: 2032-06-03→ Common Stock, par value $0.005 per share (664,800 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable over four years (subject to continued service), with 25% of the shares vesting on May 31, 2023 and the remaining shares vesting in 36 substantially equal monthly installments thereafter.